ArticleInternational journal of clinical pharmacy2018

Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.

Guillaume Hébert et al.PubMed ↗Publisher ↗

No numbers read from the abstract.